CanSino Biologics, Inc. Class H(HK:6185)
HK$21.14-0.86 (-3.91%)
HK:6185
CanSino Biologics, Inc. Class H financials statements
HK$21.14
At close:-0.86 (-3.91%)
Want to see HK:6185 full AI Analyst Report?
CanSino Biologics, Inc. Class H (6185) Income Statement
7 Followers
CanSino Biologics, Inc. Class H Income Statement
Last quarter (Q3 2026), CanSino Biologics, Inc. Class H's total revenue was ¥332.43M, an increase of 7.19% from the same quarter last year. In Q3, CanSino Biologics, Inc. Class H's net income was ¥17.01M. See CanSino Biologics, Inc. Class H’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 1.03B | ¥ 846.34M | ¥ 345.18M | ¥ 1.03B | ¥ 4.30B | |
| ¥ 681.82M | ¥ 601.91M | ¥ -876.02M | ¥ -186.61M | ¥ 3.00B | |
| ¥ 794.94M | ¥ 958.80M | ¥ 1.16B | ¥ 1.18B | ¥ 1.20B | |
| Depreciation and Amortization | ¥ 174.10M | ¥ 211.38M | ¥ 269.05M | ¥ 196.36M | ¥ 88.54M |
| ¥ 60.98M | ¥ -163.84M | ¥ -1.65B | ¥ -1.30B | ¥ 1.87B | |
| ¥ -113.12M | ¥ -375.22M | ¥ -2.04B | ¥ -1.37B | ¥ 1.94B | |
| ¥ 134.30M | ¥ -5.98M | ¥ 56.30M | ¥ 184.74M | ¥ -4.01M | |
| ¥ 21.18M | ¥ -381.20M | ¥ -1.98B | ¥ -1.18B | ¥ 1.94B | |
| ¥ 27.15M | ¥ -378.88M | ¥ -1.48B | ¥ -909.43M | ¥ 1.91B | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 0.11 | ¥ -1.53 | ¥ -6.01 | ¥ -3.68 | ¥ 7.74 |
| Diluted EPS | ¥ 0.11 | ¥ -1.53 | ¥ -6.01 | ¥ -3.68 | ¥ 7.74 |
| Weighted Average Shares Outstanding | 253.38M | 247.64M | 246.77M | 247.02M | 247.45M |
| Weighted Average Shares Outstanding (Diluted) | 253.38M | 247.64M | 246.77M | 247.02M | 247.45M |
Currency in CNY

